Open access
Oct 2026
Chronic Spontaneous Urticaria Endotypes: Exploratory Proteomic Analysis in the Benralizumab ARROYO Study.
In this post hoc analysis funded by AstraZeneca, benralizumab reduced eosinophil‐related protein biomarker expression. Benralizumab reduced eosinophil‐derived neurotoxin concentrations, which were dose‐independent and irrespective of BHRA status.
E. Rodríguez-Suárez, M. Cardner, D. Muthas et al.
· Clinical and Experimental Al... · 0 citations